TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22

Benzinga Newsdesk www.benzinga.com Neutral 60.5%

Neg 0% Neu 60.5% Pos 0%

TD Cowen analyst Stacy Ku initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy rating and announces Price Target of $22.